Accelerated degradation of retinoic acid by activated microglia

Journal of Neuroimmunology

Volumn 256, Issue 1-2, 2013, Pages 1-6

  Hellmann Regen, Julian ^a   Kronenberg, Golo ^a   Uhlemann, Ria ^a   Freyer, Dorette ^a   Endres, Matthias ^a   Gertz, Karen ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cytochrome P450 enzymes; LPS; Microglia; Neuroinflammation; Retinoic acid

Indexed keywords

CYTOCHROME; CYTOCHROME P450 26A1; CYTOCHROME P450 2C; CYTOCHROME P450 3A4; LIAROZOLE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PROTEIN CYP26B1; RETINOIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIODEGRADATION; CATABOLISM; CELL ACTIVATION; CYTOKINE RELEASE; MICROGLIA; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; BRAIN; CELLS, CULTURED; CYTOCHROME P-450 ENZYME SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; IMIDAZOLES; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MICROGLIA; NITRIC OXIDE; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; RNA, MESSENGER; TIME FACTORS; TRETINOIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84875367208     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2012.11.005     Document Type: Article

References (64)

1. Abu-Abed S., Dolle P., Metzger D., Beckett B., Chambon P., Petkovich M. The retinoic acid-metabolizing enzyme, CYP26A1, is essential for normal hindbrain patterning, vertebral identity, and development of posterior structures. Genes Dev. 2001, 15:226-240.
2. Ahlemeyer B., Huhne R., Krieglstein J. Retinoic acid potentiated the protective effect of NGF against staurosporine-induced apoptosis in cultured chick neurons by increasing the trkA protein expression. J. Neurosci. Res. 2000, 60:767-778.
3. Aoto J., Nam C.I., Poon M.M., Ting P., Chen L. Synaptic signaling by all-trans retinoic acid in homeostatic synaptic plasticity. Neuron 2008, 60:308-320.
4. Cacci E., Ajmone-Cat M.A., Anelli T., Biagioni S., Minghetti L. In vitro neuronal and glial differentiation from embryonic or adult neural precursor cells are differently affected by chronic or acute activation of microglia. Glia 2008, 56:412-425.
5. Chao C.C., Hu S., Molitor T.W., Shaskan E.G., Peterson P.K. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J. Immunol. 1992, 149:2736-2741.
6. Charles N.A., Holland E.C., Gilbertson R., Glass R., Kettenmann H. The brain tumor microenvironment. Glia 2012, 60:502-514.
7. Cheung B., Hocker J.E., Smith S.A., Reichert U., Norris M.D., Haber M., Stewart B.W., Marshall G.M. Retinoic acid receptors beta and gamma distinguish retinoid signals for growth inhibition and neuritogenesis in human neuroblastoma cells. Biochem. Biophys. Res. Commun. 1996, 229:349-354.
8. Combs C.K., Karlo J.C., Kao S.C., Landreth G.E. Beta-amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J. Neurosci. 2001, 21:1179-1188.
9. Davies C.A., Loddick S.A., Toulmond S., Stroemer R.P., Hunt J., Rothwell N.J. The progression and topographic distribution of interleukin-1beta expression after permanent middle cerebral artery occlusion in the rat. J. Cereb. Blood Flow Metab. 1999, 19:87-98.
10. Dheen S.T., Jun Y., Yan Z., Tay S.S., Ling E.A. Retinoic acid inhibits expression of TNF-alpha and iNOS in activated rat microglia. Glia 2005, 50:21-31.
11. Ding Y., Qiao A., Wang Z., Goodwin J.S., Lee E.S., Block M.L., Allsbrook M., McDonald M.P., Fan G.H. Retinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model. J. Neurosci. 2008, 28:11622-11634.
12. Dogra S.C., Whitelaw M.L., May B.K. Transcriptional activation of cytochrome P450 genes by different classes of chemical inducers. Clin. Exp. Pharmacol. Physiol. 1998, 25:1-9.
13. Ekdahl C.T., Claasen J.H., Bonde S., Kokaia Z., Lindvall O. Inflammation is detrimental for neurogenesis in adult brain. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:13632-13637.
14. Gehrmann J., Banati R.B., Wiessner C., Hossmann K.A., Kreutzberg G.W. Reactive microglia in cerebral ischaemia: an early mediator of tissue damage?. Neuropathol. Appl. Neurobiol. 1995, 21:277-289.
15. Gehrmann J., Matsumoto Y., Kreutzberg G.W. Microglia: intrinsic immuneffector cell of the brain. Brain Res. Brain Res. Rev. 1995, 20:269-287.
16. Gertz K., Kronenberg G., Kalin R.E., Baldinger T., Werner C., Balkaya M., Eom G.D., Hellmann-Regen J., Krober J., Miller K.R., Lindauer U., Laufs U., Dirnagl U., Heppner F.L., Endres M. Essential role of interleukin-6 in post-stroke angiogenesis. Brain 2012, 135:1964-1980.
17. Graeber M.B. Changing face of microglia. Science 2010, 330:783-788.
18. Graeber M.B., Streit W.J. Microglia: biology and pathology. Acta Neuropathol. 2010, 119:89-105.
19. Hagglund M., Berghard A., Strotmann J., Bohm S. Retinoic acid receptor-dependent survival of olfactory sensory neurons in postnatal and adult mice. J. Neurosci. 2006, 26:3281-3291.
20. Hanisch U.K. Microglia as a source and target of cytokines. Glia 2002, 40:140-155.
21. Hellmann-Regen J., Gertz K., Uhlemann R., Colla M., Endres M., Kronenberg G. Retinoic acid as target for local pharmacokinetic interaction with modafinil in neural cells. Eur. Arch. Psychiatry Clin. Neurosci. 2012, 262:697-704.
22. Hetier E., Ayala J., Bousseau A., Denefle P., Prochiantz A. Amoeboid microglial cells and not astrocytes synthesize TNF-alpha in Swiss mouse brain cell cultures. Eur. J. Neurosci. 1990, 2:762-768.
23. Hoehn B.D., Palmer T.D., Steinberg G.K. Neurogenesis in rats after focal cerebral ischemia is enhanced by indomethacin. Stroke 2005, 36:2718-2724.
24. Hornberg M., Gussing F., Berghard A., Bohm S. Retinoic acid selectively inhibits death of basal vomeronasal neurons during late stage of neural circuit formation. J. Neurochem. 2009, 110:1263-1275.
25. Howell S.R., Shirley M.A., Ulm E.H. Effects of retinoid treatment of rats on hepatic microsomal metabolism and cytochromes P450. Correlation between retinoic acid receptor/retinoid x receptor selectivity and effects on metabolic enzymes. Drug Metab. Dispos. 1998, 26:234-239.
26. Idres N., Marill J., Chabot G.G. Regulation of CYP26A1 expression by selective RAR and RXR agonists in human NB4 promyelocytic leukemia cells. Biochem. Pharmacol. 2005, 69:1595-1601.
27. Jacobs S., Lie D.C., DeCicco K.L., Shi Y., DeLuca L.M., Gage F.H., Evans R.M. Retinoic acid is required early during adult neurogenesis in the dentate gyrus. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:3902-3907.
28. Kang S., Duell E.A., Kim K.J., Voorhees J.J. Liarozole inhibits human epidermal retinoic acid 4-hydroxylase activity and differentially augments human skin responses to retinoic acid and retinol in vivo. J. Invest. Dermatol. 1996, 107:183-187.
29. Kim B., Lee J.H., Yang M.S., Jou I., Joe E.H. Retinoic acid enhances prostaglandin E2 production through increased expression of cyclooxygenase-2 and microsomal prostaglandin E synthase-1 in rat brain microglia. J. Neurosci. Res. 2008, 86:1353-1360.
30. Lane M.A., Bailey S.J. Role of retinoid signalling in the adult brain. Prog. Neurobiol. 2005, 75:275-293.
31. Langston J.W., Forno L.S., Tetrud J., Reeves A.G., Kaplan J.A., Karluk D. Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Ann. Neurol. 1999, 46:598-605.
32. Liu W., Shen Y., Plane J.M., Pleasure D.E., Deng W. Neuroprotective potential of erythropoietin and its derivative carbamylated erythropoietin in periventricular leukomalacia. Exp. Neurol. 2011, 230:227-239.
33. Lynch M.A. The multifaceted profile of activated microglia. Mol. Neurobiol. 2009, 40:139-156.
34. Maden M. Retinoic acid in the development, regeneration and maintenance of the nervous system. Nat. Rev. Neurosci. 2007, 8:755-765.
35. Markovic D.S., Glass R., Synowitz M., Rooijen N., Kettenmann H. Microglia stimulate the invasiveness of glioma cells by increasing the activity of metalloprotease-2. J. Neuropathol. Exp. Neurol. 2005, 64:754-762.
36. Matsushita H., Hijioka M., Hisatsune A., Isohama Y., Shudo K., Katsuki H. A retinoic acid receptor agonist Am80 rescues neurons, attenuates inflammatory reactions, and improves behavioral recovery after intracerebral hemorrhage in mice. J. Cereb. Blood Flow Metab. 2011, 31:222-234.
37. Munch G., Gasic-Milenkovic J., Dukic-Stefanovic S., Kuhla B., Heinrich K., Riederer P., Huttunen H.J., Founds H., Sajithlal G. Microglial activation induces cell death, inhibits neurite outgrowth and causes neurite retraction of differentiated neuroblastoma cells. Exp. Brain Res. 2003, 150:1-8.
38. Nishida Y., Sugahara-Kobayashi M., Takahashi Y., Nagata T., Ishikawa K., Asai S. Screening for control genes in mouse hippocampus after transient forebrain ischemia using high-density oligonucleotide array. J. Pharmacol. Sci. 2006, 101:52-57.
39. Olson C.R., Mello C.V. Significance of vitamin A to brain function, behavior and learning. Mol. Nutr. Food Res. 2010, 54:489-495.
40. Ossola B., Schendzielorz N., Chen S.H., Bird G.S., Tuominen R.K., Mannisto P.T., Hong J.S. Amantadine protects dopamine neurons by a dual action: reducing activation of microglia and inducing expression of GNDF in astroglia. Neuropharmacology 2011, 61:574-582.
41. Otto D.M., Henderson C.J., Carrie D., Davey M., Gundersen T.E., Blomhoff R., Adams R.H., Tickle C., Wolf C.R. Identification of novel roles of the cytochrome p450 system in early embryogenesis: effects on vasculogenesis and retinoic acid homeostasis. Mol. Cell. Biol. 2003, 23:6103-6116.
42. Papalopulu N., Clarke J.D., Bradley L., Wilkinson D., Krumlauf R., Holder N. Retinoic acid causes abnormal development and segmental patterning of the anterior hindbrain in Xenopus embryos. Development 1991, 113:1145-1158.
43. Pascussi J.M., Gerbal-Chaloin S., Drocourt L., Maurel P., Vilarem M.J. The expression of CYP2B6, CYP2C9 and CYP3A4 genes: a tangle of networks of nuclear and steroid receptors. Biochim. Biophys. Acta 2003, 1619:243-253.
44. Regen T., van Rossum D., Scheffel J., Kastriti M.E., Revelo N.H., Prinz M., Bruck W., Hanisch U.K. CD14 and TRIF govern distinct responsiveness and responses in mouse microglial TLR4 challenges by structural variants of LPS. Brain Behav. Immun. 2011, 25:957-970.
45. Reijntjes S., Rodaway A., Maden M. The retinoic acid metabolising gene, CYP26B1, patterns the cartilaginous cranial neural crest in zebrafish. Int. J. Dev. Biol. 2007, 51:351-360.
46. Ribes V., Fraulob V., Petkovich M., Dolle P. The oxidizing enzyme CYP26a1 tightly regulates the availability of retinoic acid in the gastrulating mouse embryo to ensure proper head development and vasculogenesis. Dev. Dyn. 2007, 236:644-653.
47. Ricciardi-Castagnoli P., Pirami L., Righi M., Sacerdote P., Locatelli V., Bianchi M., Sassano M., Valsasnini P., Shammah S., Panerai A.E. Cellular sources and effects of tumor necrosis factor-alpha on pituitary cells and in the central nervous system. Ann. N. Y. Acad. Sci. 1990, 594:156-168.
48. Rodriguez-Tebar A., Rohrer H. Retinoic acid induces NGF-dependent survival response and high-affinity NGF receptors in immature chick sympathetic neurons. Development 1991, 112:813-820.
49. Ross A.C., Zolfaghari R. Cytochrome P450s in the regulation of cellular retinoic acid metabolism. Annu. Rev. Nutr. 2011, 31:65-87.
50. 2+ activated SK3 channel is expressed in microglia in the rat striatum and contributes to microglia-mediated neurotoxicity in vitro. J. Neuroinflammation 2010, 7:4.
51. Sonneveld E., van den Brink C.E., van der Leede B.M., Schulkes R.K., Petkovich M., van der Burg B., van der Saag P.T. Human retinoic acid (RA) 4-hydroxylase (CYP26) is highly specific for all-trans-RA and can be induced through RA receptors in human breast and colon carcinoma cells. Cell Growth Differ. 1998, 9:629-637.
52. Stoilov I., Jansson I., Sarfarazi M., Schenkman J.B. Roles of cytochrome p450 in development. Drug Metabol. Drug Interact. 2001, 18:33-55.
53. Thatcher J.E., Isoherranen N. The role of CYP26 enzymes in retinoic acid clearance. Expert Opin. Drug Metab. Toxicol. 2009, 5:875-886.
54. van Neerven S., Nemes A., Imholz P., Regen T., Denecke B., Johann S., Beyer C., Hanisch U.K., Mey J. Inflammatory cytokine release of astrocytes in vitro is reduced by all-trans retinoic acid. J. Neuroimmunol. 2010, 229:169-179.
55. Van Wauwe J.P., Coene M.C., Goossens J., Cools W., Monbaliu J. Effects of cytochrome P-450 inhibitors on the in vivo metabolism of all-trans-retinoic acid in rats. J. Pharmacol. Exp. Ther. 1990, 252:365-369.
56. Van Wauwe J., Van Nyen G., Coene M.C., Stoppie P., Cools W., Goossens J., Borghgraef P., Janssen P.A. Liarozole, an inhibitor of retinoic acid metabolism, exerts retinoid-mimetic effects in vivo. J. Pharmacol. Exp. Ther. 1992, 261:773-779.
57. Wang K., Chen S., Xie W., Wan Y.J. Retinoids induce cytochrome P450 3A4 through RXR/VDR-mediated pathway. Biochem. Pharmacol. 2008, 75:2204-2213.
58. Wang C., Kane M.A., Napoli J.L. Multiple retinol and retinal dehydrogenases catalyze all-trans-retinoic acid biosynthesis in astrocytes. J. Biol. Chem. 2011, 286:6542-6553.
59. White J.A., Guo Y.D., Baetz K., Beckett-Jones B., Bonasoro J., Hsu K.E., Dilworth F.J., Jones G., Petkovich M. Identification of the retinoic acid-inducible all-trans-retinoic acid 4-hydroxylase. J. Biol. Chem. 1996, 271:29922-29927.
60. Xi J., Yang Z. Expression of RALDHs (ALDH1As) and CYP26s in human tissues and during the neural differentiation of P19 embryonal carcinoma stem cell. Gene Expr. Patterns 2008, 8:438-442.
61. Xu J., Storer P.D., Chavis J.A., Racke M.K., Drew P.D. Agonists for the peroxisome proliferator-activated receptor-alpha and the retinoid X receptor inhibit inflammatory responses of microglia. J. Neurosci. Res. 2005, 81:403-411.
62. Xu J., Chavis J.A., Racke M.K., Drew P.D. Peroxisome proliferator-activated receptor-alpha and retinoid X receptor agonists inhibit inflammatory responses of astrocytes. J. Neuroimmunol. 2006, 176:95-105.
63. Zhang W., Purchio A., Chen K., Burns S.M., Contag C.H., Contag P.R. In vivo activation of the human CYP3A4 promoter in mouse liver and regulation by pregnane X receptors. Biochem. Pharmacol. 2003, 65:1889-1896.
64. Zhu L.H., Bi W., Qi R.B., Wang H.D., Lu D.X. Luteolin inhibits microglial inflammation and improves neuron survival against inflammation. Int. J. Neurosci. 2011, 121:329-336.